KEMTA masterclass: Using early Health Technology Assessment (HTA) to estimate the cost-effectiveness and support strategic decisions for innovative technologies
-
Masterclass
Using early Health Technology Assessment (HTA) to estimate the cost-effectiveness and support strategic decisions for innovative technologies
By: Sabine Grimm/Bram Ramaekers
Language: English
The masterclasses will take place via Teams of Zoom. You can register by sending an e-mail to: Irene.vrancken@mumc.nl.
KEMTA (Clinical Epidemiology & Medical Technology Assessment) of MUMC+ regularly organises masterclasses for employees interested in research methods. The masterclasses give short insights into a variety of topics, from the basics of setting up research to statistics and hot topics such as early HTA.
Also read
-
PhD defence Qingfeng Wen
" An Integrative miRNA Approach to Alzheimer's Disease: From Peripheral Biomarkers to Central Brain Mechanisms"PhD defence16 Jun -
PhD defence Sylvester Raymond Bruls-Groen
" Towards personalized care: Unraveling biopsychosocial profiles in disorders of the gut-brain interaction"PhD defence18 Jun -
PhD defence Lisanne Arayess
" Tailored To Thrive: A Personalised Approach to Paediatric Overweight"PhD defence18 Jun